ABCA2
Basic information
Region (hg38): 9:137007234-137028915
Previous symbols: [ "ABC2" ]
Links
Phenotypes
GenCC
Source:
- schizophrenia (Limited), mode of inheritance: Unknown
- intellectual developmental disorder with poor growth and with or without seizures or ataxia (Limited), mode of inheritance: AR
- intellectual developmental disorder with poor growth and with or without seizures or ataxia (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder with poor growth and with or without seizures or ataxia | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 29302074; 30237576; 31047799 |
ClinVar
This is a list of variants' phenotypes submitted to
- Intellectual developmental disorder with poor growth and with or without seizures or ataxia (4 variants)
- not provided (2 variants)
- Ataxia with Dysarthria (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 73 | 13 | 87 | |||
missense | 197 | 12 | 212 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 3 | 10 | 2 | 16 | |
non coding | 15 | 24 | ||||
Total | 5 | 4 | 203 | 90 | 31 |
Variants in ABCA2
This is a list of pathogenic ClinVar variants found in the ABCA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-137007762-A-G | Intellectual developmental disorder with poor growth and with or without seizures or ataxia | Benign (Jul 14, 2021) | ||
9-137007943-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
9-137007963-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
9-137008260-A-G | Intellectual developmental disorder with poor growth and with or without seizures or ataxia | Benign (Jul 14, 2021) | ||
9-137008334-G-C | Intellectual developmental disorder with poor growth and with or without seizures or ataxia | Benign (Jul 14, 2021) | ||
9-137008345-C-G | Intellectual developmental disorder with poor growth and with or without seizures or ataxia | Benign (Jul 14, 2021) | ||
9-137008428-G-A | not specified | Likely benign (Jan 16, 2024) | ||
9-137008444-T-C | not specified | Uncertain significance (Dec 13, 2022) | ||
9-137008451-C-T | not specified | Uncertain significance (Jan 20, 2023) | ||
9-137008453-G-A | Uncertain significance (Mar 22, 2023) | |||
9-137008459-A-C | not specified | Uncertain significance (Dec 21, 2023) | ||
9-137008467-G-A | Likely benign (Jan 01, 2024) | |||
9-137008487-C-T | not specified | Uncertain significance (May 05, 2023) | ||
9-137008501-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
9-137008510-C-T | not specified | Uncertain significance (May 13, 2024) | ||
9-137008515-C-T | ABCA2-related disorder | Likely benign (Apr 04, 2019) | ||
9-137008516-C-T | ABCA2-related disorder • not specified | Uncertain significance (Apr 18, 2023) | ||
9-137008517-G-A | not specified | Uncertain significance (Apr 12, 2022) | ||
9-137008527-G-A | ABCA2-related disorder | Likely benign (Mar 05, 2019) | ||
9-137008538-C-G | not specified | Uncertain significance (Oct 14, 2023) | ||
9-137008556-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
9-137008575-C-T | Likely benign (Jul 01, 2022) | |||
9-137008616-C-G | Intellectual developmental disorder with poor growth and with or without seizures or ataxia | Uncertain significance (Mar 01, 2022) | ||
9-137008616-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
9-137008732-T-C | not specified | Uncertain significance (Oct 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCA2 | protein_coding | protein_coding | ENST00000341511 | 49 | 21682 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.30e-10 | 124440 | 0 | 32 | 124472 | 0.000129 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.91 | 1029 | 1.58e+3 | 0.652 | 0.000113 | 15623 |
Missense in Polyphen | 314 | 693.66 | 0.45267 | 6845 | ||
Synonymous | -3.36 | 849 | 733 | 1.16 | 0.0000593 | 5063 |
Loss of Function | 8.92 | 12 | 115 | 0.104 | 0.00000549 | 1254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000198 | 0.000193 |
Ashkenazi Jewish | 0.000203 | 0.000199 |
East Asian | 0.000167 | 0.000167 |
Finnish | 0.000115 | 0.0000928 |
European (Non-Finnish) | 0.000169 | 0.000151 |
Middle Eastern | 0.000167 | 0.000167 |
South Asian | 0.000171 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transporter, its natural substrate has not been found yet. May have a role in macrophage lipid metabolism and neural development.;
- Pathway
- Lysosome - Homo sapiens (human);ABC transporters - Homo sapiens (human);ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.298
Intolerance Scores
- loftool
- 0.00985
- rvis_EVS
- -4.24
- rvis_percentile_EVS
- 0.12
Haploinsufficiency Scores
- pHI
- 0.346
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.636
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.888
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abca2
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;lipid metabolic process;lipid transport;regulation of intracellular cholesterol transport;response to drug;cholesterol homeostasis;response to steroid hormone;transmembrane transport;response to cholesterol
- Cellular component
- lysosome;lysosomal membrane;endosome;microtubule organizing center;endosome membrane;membrane;integral component of membrane;cytoplasmic vesicle;ATP-binding cassette (ABC) transporter complex;intracellular membrane-bounded organelle
- Molecular function
- nucleotide binding;lipid transporter activity;ATP binding;ATPase activity;ATPase activity, coupled to transmembrane movement of substances